This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chengdu Mfs Pharma. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Haijun Ma: Innovator in Anesthetic Compounds
Introduction
Haijun Ma is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of anesthetic compounds, particularly through his innovative research and development efforts. His work focuses on the creation of new chemical compounds that have the potential to improve medical practices.
Latest Patents
Haijun Ma holds a patent for a substituted nitrogen heterocyclic compound and its anesthetic effects. The invention discloses a chemical compound that exhibits good central nervous system inhibition effects. This compound is capable of generating sedative, hypnotic, and general anesthetic effects, as well as controlling status epilepticus. The compound is characterized by a rapid onset of action and quick recovery, while maintaining positive anesthetic activity. Additionally, it has minimal inhibitory effects on adrenocortical function and low side effects, addressing technical challenges in the field. This invention provides a new option for clinical screening and preparation of sedative and anesthetic drugs.
Career Highlights
Haijun Ma is associated with Chengdu Mfs Pharma Co., Ltd., where he continues to advance his research in anesthetic compounds. His work has garnered attention for its potential applications in clinical settings, particularly in the development of safer and more effective anesthetic drugs.
Collaborations
Haijun Ma collaborates with Jin Liu, contributing to the innovative research environment at Chengdu Mfs Pharma Co., Ltd. Their partnership enhances the development of new anesthetic solutions.
Conclusion
Haijun Ma's contributions to the field of anesthetics through his patented innovations highlight his role as a key inventor in the pharmaceutical industry. His work promises to impact medical practices positively and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile